Rapport Therapeutics Inc
NASDAQ:RAPP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
Kelsian Group Ltd
ASX:KLS
|
AU |
|
G
|
Gullewa Ltd
ASX:GUL
|
AU |
|
Geely Automobile Holdings Ltd
HKEX:175
|
HK |
|
E
|
Endeavour Silver Corp
NYSE:EXK
|
CA |
|
OEM International AB
F:OEA1
|
SE |
|
G
|
G-Tech Optoelectronics Corp
TWSE:3149
|
TW |
|
Kalyani Steels Ltd
NSE:KSL
|
IN |
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
Anglo Australian Resources NL
ASX:AAR
|
AU |
|
Gemini Group Global Corp
OTC:GMNI
|
US |
|
I
|
Impact Silver Corp
OTC:ISVLF
|
CA |
|
J
|
Japan Airlines Co Ltd
F:JAL
|
JP |
|
First Capital Inc
NASDAQ:FCAP
|
US |
|
Bouygues SA
PAR:EN
|
FR |
|
Montage Technology Co Ltd
SSE:688008
|
CN |
|
N
|
NeoTechnicalSystem Co Ltd
KOSDAQ:085910
|
KR |
|
M
|
Mien Trung Power Investment and Development JSC
VN:SEB
|
VN |
|
V
|
VTM Ltd
BSE:532893
|
IN |
|
Patria Investments Ltd
NASDAQ:PAX
|
KY |
|
F
|
Fractal Gaming Group AB
F:5HS
|
SE |
Bankruptcy Probability
Rapport Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rapport Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
1.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rapport Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rapport Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
